REGN — Regeneron Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual balance sheet for Regeneron Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	5,695	7,742	10,845	9,013	8,605
Net Total Accounts Receivable
Net Total Receivables	6,037	5,329	5,667	6,212	5,741
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	14,015	15,884	19,479	18,661	18,022
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3,482	3,763	4,224	4,817	5,366
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	25,435	29,215	33,080	37,759	40,559
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3,933	3,141	3,423	3,944	4,368
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	6,666	6,551	7,107	8,406	9,302
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	18,769	22,664	25,973	29,354	31,257
Total Liabilities & Shareholders' Equity	25,435	29,215	33,080	37,759	40,559
Total Common Shares Outstanding